Maria Fardis insider trades: Pharmacyclics (PCYC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Maria reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 13, 2014 | PCYC | ↓ Sell | 3,000 | $141.30 | $424K | Direct | Nov 17, 2014 (4d) |
| Nov 7, 2014 | PCYC | ↓ Sell | 5,000 | $134.50 | $673K | Direct | Nov 10, 2014 (3d) |
| Aug 13, 2014 | PCYC | ↓ Sell | 4,000 | $121.01 | $484K | Direct | Aug 15, 2014 (2d) |
| Mar 5, 2014 | PCYC | ↓ Sell | 3,000 | $140.50 | $422K | Direct | Mar 7, 2014 (2d) |
| Jan 8, 2013 | PCYC | ↓ Sell | 2,500 | $65.00 | $163K | Direct | Jan 9, 2013 (1d) |
| Jan 7, 2013 | PCYC | ↓ Sell | 3,500 | $64.20 | $225K | Direct | Jan 7, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Maria Fardis's insider trades
Maria Fardis is Chief of Oncology Ops & Allian at Pharmacyclics (PCYC). Since Jan 7, 2013, Maria has reported no open-market purchases and 6 sales worth $2.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), shares withheld for taxes (8 filings), option exercises (5 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCYC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.